Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Drug Makers Met with Trump to Argue against Senate Pricing Bill

Michael Erman, Carl O'Donnell, Caroline Humer and Roberta Rampton  |  

(Reuters)—The main pharmaceutical industry lobbying group said on Thursday it and some drugmakers met with President Donald Trump to voice opposition to a bipartisan U.S. Senate bill that aims to lower prescription drug prices. The White House, which has said it backs the legislation, has promised to bring down drug prices for U.S. consumers, an…

Samsung Bioepis Humira Biosimilar Wins FDA Approval

Aakash Jagadeesh Babu and Bernard Orr  |  

(Reuters)—The U.S. Food and Drug Administration approved Samsung Bioepis Co. Ltd.’s biosimilar to AbbVie Inc.’s blockbuster rheumatoid arthritis treatment Humira, the health agency said on Tuesday. The drug, Hadlima, was developed by South Korea’s Samsung Bioepis and comes with a boxed warning, the FDA’s harshest. The agency flagged increased risk of serious infections, including tuberculosis…

Pets May Help Older Adults Manage Chronic Pain

Carolyn Crist  |  

(Reuters Health)—People with pets may be able to use their companion animals to practice techniques for managing chronic pain without medication, researchers say. In focus group interviews, pet owners over age 70 with chronic pain said their pets brought them joy and laughter, helped them relax, kept them active and promoted other good habits that…

UnitedHealth Boosts Earnings Forecast, Set to Pass Price Discounts to Patients

Tamara Mathias and Caroline Humer  |  

July 18 (Reuters)—UnitedHealth Group Inc. will stick with its decision to pass on drug maker discounts to patients to help them beat rising medicine prices despite the U.S. government having withdrawn a similar proposed policy in its health programs, its top executive said on Thursday. “You can expect us not to change our stance on…